CLASP IID one year data confirms safety and efficacy of PASCAL system for degenerative mitral regurgitation – Edwards Life Sciences
Edwards Lifesciences Corporation announced one-year results from CLASP IID, the first randomized controlled trial that directly compares two contemporary mitral transcatheter edge-to-edge repair (TEER) therapies, as well as… read more.
